Share this article on:

Overweight and obesity in the mortality rate data: current evidence and research issues

SEIDELL, JACOB C.; VISSCHER, TOMMY L. S.; HOOGEVEEN, RUDOLF T.

Medicine & Science in Sports & Exercise: November 1999 - Volume 31 - Issue 11 - p S597
Roundtable Consensus Statement

SEIDELL, J. C., T. L. S. VISSCHER, and R. T. HOOGEVEEN. Overweight and obesity in the mortality rate data: current evidence and research issues. Med. Sci. Sports Exerc., Vol. 31, No. 11, Suppl., pp. S597–S601, 1999.

Purpose: The relation between indicators of overweight (body mass index (BMI)) and all-cause mortality and factors that potentially affect such a relationship were reviewed.

Methods: The literature was reviewed.

Results: Although there are many reports on the relationship between indicators of overweight (such as BMI) and all-cause mortality, there are no two studies that have been analyzed identically. It is now usually assumed that there is a U- or J-shaped association between BMI and mortality, but there are many issues that remain unsolved until today. These issues include the effects of: adequate control for cigarette smoking; adequate control for (sub)clinical disease at baseline; adequate control for intermediate risk factors; adequate measures for exposure to obesity; age, period, and cohort effects; adequate control for underlying lifestyle factors; adequate control or stratification for ethnicity and socioeconomic status; effects of sample size and duration of follow-up; and reliance on self-reported body weight and height.

Conclusion: The literature is dominated by studies in young adult and middle-aged white inhabitants of North America and Europe. In those populations, it seems well accepted that lowest mortality is in the range of BMI between 18.5 and 25 kg·m−2. When BMI reached values of 30 kg·m−2 or more, mortality is substantially elevated by about 50–150%. These results may not be generalizable to other populations, and more studies are needed. All evidence is of category C (observational studies).

Department of Chronic Diseases Epidemiology, National Institute of Public Health and the Environment, 3720 BA Bilthoven, THE NETHERLANDS

Address for correspondence: Jacob C. Seidell, Ph.D., Department of Chronic Diseases Epidemiology, National Institute of Public Health and the Environment, P.O. Box 1, 3720 BA Bilthoven, The Netherlands; E-mail: J.Seidell@RIVM.NL.

Roundtable held February 4–7, 1999, Indianapolis, IN.

© 1999 Lippincott Williams & Wilkins, Inc.